A health care revolution threatened

“Personalized” medicines represent a health care revolution. Thanks to sophisticated and new diagnostic technologies, medical scientists have created hyper-targeted treatments keyed into the specific physiological traits of individual patients. These drugs are more effective than their conventional counterparts and less likely to cause adverse side effects. And they’ve proven valuable in the fight against diseases previously considered untreatable.

But drug developers need smart laws to flourish. Unfortunately, over just the last year, federal lawmakers have taken several steps that could smother pharmaceutical innovation and compromise private industry’s ability and willingness to pursue more lifesaving breakthroughs.

First, the good news. The market for personalized biopharmaceutical drugs is on track to double in size to $18 billion by 2019.
 
Sign Up for Our Email Newsletter

RECENT NEWS

Vaper Madness

Vaper Madness

E-cigarettes, while not a cure for nicotine dependence, can help reduce the death and disease caused by combustible tobac...  Read more

Three ways Congress can lower seniors’ pharmacy bills

Three ways Congress can lower seniors’ pharmacy bills

Here are three ways Congress can improve Medicare Part D to lower seniors’ drug tabs....  Read more

FDA Hears Concerns About The Unregulated CBD Market

FDA Hears Concerns About The Unregulated CBD Market

What most speakers agreed on: the need for federal CBD oversight for production quality, more testing and research and be...  Read more

DRUGWONKS BLOG